US 9523691
Use of the olfactomedin-4 protein (OLFM4) in colorectal cancer diagnosis
granted A61KA61K31/4745A61K31/513
Quick answer
US patent 9523691 (Use of the olfactomedin-4 protein (OLFM4) in colorectal cancer diagnosis) held by INSTITUT DE CANCEROLOGIE DE L'OUEST expires Mon Dec 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- INSTITUT DE CANCEROLOGIE DE L'OUEST
- Grant date
- Tue Dec 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/4745, A61K31/513, A61K31/519, A61K31/555